Lupin and Dr Reddy's launch Geodon into rapidly genericising schizophrenia market
This article was originally published in Scrip
Executive Summary
Indian companies Dr Reddy's Laboratories and Lupin have announced the launch of their generic versions of Pfizer's schizophrenia drug Geodon (ziprasidone) in the US, with shared exclusivity as early filers of ANDAs for the product.